首页|含WW域的氧化还原酶在颅内动脉瘤中表达分析及作为分子标志物的研究

含WW域的氧化还原酶在颅内动脉瘤中表达分析及作为分子标志物的研究

扫码查看
目的 目前颅内动脉瘤(IA)尚无明确的早期筛查分子标志物,分析含WW域的氧化还原酶(WWOX)作为IA筛查指标的价值。方法 通过病例对照研究对2021年至2023年采集自新疆医科大学第一附属医院IA患者102例(男41例,女61例;未破裂者78例,破裂者24例)和健康人群100例(男59例,女41例)血液及20例组织样本(IA组织8例,颞浅动脉12例)行实时荧光定量聚合酶链反应(RT-qPCR)及免疫荧光,对42份血浆样本(IA组男8例,女13例;对照组男10例,女11例)行酶联免疫吸附测定(ELISA)检测,经多因素逻辑回归分析后行受试者工作特征曲线(ROC)建模,综合评价WWOX基因与IA的关系。两组间比较采用独立样本t检验,多组间比较采用单因素方差分析。结果 组织中WWOX基因含量IA组低于对照组(15。100±12。751比0。788±0。598,t=3。16,P<0。01),免疫荧光染色示IA中WWOX水平降低。血液中WWOX基因含量IA组高于健康人群(0。715±1。647比1。484±0。971,t=7。524,P<0。01)。对照组低于未破裂及破裂组(0。701±0。152 比 1。434±0。745 比 1。005±0。597,F=40。52,P<0。01)。血液中女性 IA 组高于男性 IA 组(0。924±0。476 比 1。601±0。916,t=3。845,P<0。01)。ELISA 检测提示 WWOX 蛋白含量IA 组高于对照组(148。651±18。071 比 169。366±25。998,t=2。642,P<0。05)。血液和血浆 ROC 曲线结果示曲线往左上偏移(AUC=0。762 4,误差0。035 73;AUC=0。727 9,误差0。088 67)。结论 WWOX参与IA的发生发展,血液中WWOX基因可作为IA早期临床筛查的分子标志物。
Expression of WW domain-containing oxidoreductase in intracranial aneurysms and as a molecular marker
Objective At present,there is no clear molecular markers for early screening of in-tracranial aneurysms(IA).The value of WW domain-containing oxidoreductase(WWOX)as an IA screen-ing indicator was analyzed.Methods Through a case-control study,102 IA patients(41 males and 61 fe-males;78 unruptured and 24 ruptured)and 100 healthy people(59 males and 61 females)and 20 tissue samples(8 cases of IA tissue,12 cases of superficial temporal artery)collected from the First Affiliated Hospital of Xinjiang Medical University from 2021 to 2023 were subjected to real-time fluorescence quanti-tative polymerase chain reaction(RT-qPCR)and immunofluorescence staining.Enzyme linked immunosor-bent assay(ELISA)was performed on 42 plasma samples(8 males and 13 females in the IA group;10 males and 11 females in the control group),and ROC curve modeling was performed after multi-factor Logistic regression analysis.The relationship between WWOX genes and IA was analyzed.The independ-ent sample t test was used for comparison between two groups,and one-way analysis of variance was used for comparison between multiple groups.Results The WWOX gene content in tissues of IA group was lower than that of the control group(15.100±12.751 vs.0.788±0.598,t=3.16,P<0.01),and immu-nofluorescence staining showed that WWOX levels were reduced in IA group.The blood WWOX gene con-tent in the IA group was higher than in the healthy people(0.715±1.647 vs.1.484±0.971,t=7.524,P<0.01).The blood WWOX gene content in the control group was lower than in the unruptured and rup-tured groups(0.701±0.152 vs.1.434±0.745 vs.1.005±0.597,F=40.52,P<0.01).The blood WWOX gene content in the female IA group was higher than that in the male IA group(0.924±0.476 vs.1.601±0.916,t=3.845,P<0.01).ELISA showed that the WWOX protein content in the IA group was higher than that in the control group(148.651±18.071 vs.169.366±25.998,t=2.642,P<0.05).The blood and plasma ROC curve results showed that the curves shifted to the upper left(AUC=0.762 4,error 0.035 73;AUC=0.727 9,error 0.088 67).Conclusion WWOX is involved in the occurrence and de-velopment of IA,and the WWOX gene in the blood can be used as a molecular marker for early clinical screening of IA.

Intracranial aneurysmWW domain containing oxidoreductase geneMolecular marker

文渊丰、阎泉、范国锋、程鹏、房泰鞍、王西宪、巴特·龚高昂、刘雪飞、杜郭佳

展开 >

新疆医科大学第一附属医院神经外科,乌鲁木齐 830054

颅内动脉瘤 含WW域的氧化还原酶基因 分子标志物

国家自然科学基金

82360247

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(7)
  • 12